How the Payer MSLs Can Tame the Value Discussions

Shereef Ibrahim

doi:10.4172/2167-065X.1000232

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Perspective
Clin Pharmacol Biopharm; 2021, Vol 10(8): 232
DOI: 10.4172/2167-065X.1000232

How the Payer MSLs Can Tame the Value Discussions

Shereef Ibrahim^*: Therapeutic Area Medical Manager, General Medicine Medical Affairs, Egypt Cluster, Egypt

^*Corresponding Author : Shereef Ibrahim, Therapeutic Area Medical Manager, General Medicine Medical Affairs, Egypt Cluster, Egypt, Tel: +201005777759, Email: sibrahim@amgen.com

Received Date: Aug 09, 2021 / Accepted Date: Aug 23, 2021 / Published Date: Aug 30, 2021

View PDF Download PDF

Citation: Ibrahim S (2021) How the Payer MSLs Can Tame the Value Discussions. Clin Pharmacol Biopharm, 10: 232. Doi: 10.4172/2167-065X.1000232

Copyright: © 2021 Ibrahim S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.